Concepedia

Publication | Open Access

Hypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study

DOIFull Paper Access

33

Citations

33

References

2018

Year

Andrew Brenner, Richard Zuniga, Jessica D. Sun, John Floyd, Charles P. Hart, Stew Kroll, Lisa Fichtel, David Cavazos, Laura Caflisch, Aleksandra Gruslova,
Neuro-Oncology

Abstract

Evo plus Bev was well tolerated in patients with Bev-refractory GBM, with preliminary evidence of activity that merits further investigation.

References

YearCitations

Page 1